PCSK9 Inhibition, Atherosclerotic Cardiovascular Disease and Health Economics: Challenges at the Crossroads

Journal of Clinical Lipidology - Netherlands
doi 10.1016/j.jacl.2019.07.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Stress and Atherosclerotic Cardiovascular Disease

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2014English

Public Health and Medicine at the Crossroads

Public Health Reports (1896-1970)
1952English

Bodies at the Crossroads Between Immigration and Health

Global Perspectives on Health Geography
2019English

SIRT1 and Gender Differences in Atherosclerotic Cardiovascular Disease

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2020English

Antibiotic Treatment of Atherosclerotic Cardiovascular Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

2015English

Whole Grains Protect Against Atherosclerotic Cardiovascular Disease

Proceedings of the Nutrition Society
MedicineNutritionDietetics
2003English

PCSK9 as Predictor for Recurrent Cardiovascular Disease in Familial Hypercholesterolemia

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2019English

Atherosclerotic Cardiovascular Disease in Older Adults With Diabetes Mellitus

Clinics in Geriatric Medicine
GerontologyGeriatrics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy